MedPath

blood thinner associated with an efficacy of ALTA injection sclerotherapy for bleeding hemorrhoids

Not Applicable
Conditions
hemorrhoid
D006484
Registration Number
JPRN-jRCT1030220379
Lead Sponsor
Takaaki Yano
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Recruiting
Sex
Not specified
Target Recruitment
1150
Inclusion Criteria

1.The patient who presents a bleeding symptom, and has the hemorrhoids grade classification 2 degrees or three times
2.The patient that an answer was provided by an interview one year later

Exclusion Criteria

The patient who had the lesion which underwent large intestine endoscopy for (two years) before receiving ALTA therapy, and resulted in bleeding pointed out

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
One year after the ALTA therapy enforcement, I asked about an escape symptom and a bleeding symptom and satisfaction on the telephone. I define the case that all those answers had good as Excellent and define other case as No good.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath